journal article·2025-12Open access

METTL10‐Mediated PIAS3 Methylation Links Purine Metabolism to Gastric Cancer Progression

Jinshui Tan, Huiwen Zhou, Jingsong Ma, Chensong Zhang, Yuhua Tan, Baoding Zhang, Jiabao Zhao, Ao Cheng, Chengyu Yang, Meijuan Xu, Shengyi Zhou, Yubo Xiong, Zeyang Lin, Guangchao Pan, Wenjie Ye, Mengya Zhong, Yang Yang, Yifan Zhuang, Shao‐Wei Li, Xianming Deng, Xuehui Hong

Advanced Science· Volume 12· Issue 48

Abstract

Abstract Metabolic dysregulation plays a significant role in the development of gastric cancer (GC). However, the mechanisms that control this change and its impact on GC progression remain poorly understood. In this study, it is demonstrated that methyltransferase‐like 10 (METTL10) is a key regulator of gastric tumor formation by enhancing purine metabolism in GC cells. It is discovered that METTL10 methylates the protein inhibitor of activated STAT3 (PIAS3) at the lysine 442 (K442) residue, which interferes with the interaction of PIAS3 with microphthalmia‐associated transcription factor (MITF). As a result, the sumoylation and ubiquitination of MITF by PIAS3 are reduced, leading to MITF stabilization and activation of purine metabolism. Importantly, both the accumulation of MITF and the methylation of K442 in PIAS3 are required for the oncogenic effects of METTL10, and both factors are closely linked to poor clinical outcomes in GC. Furthermore, this study identified a compound, LZQ‐02‐023‐01, which effectively induces the METTL10‐mediated ubiquitination and degradation of MITF, thereby reducing the oncogenic activity of METTL10. The findings suggest that METTL10 plays an important role in reprogramming purine metabolism, which promotes GC, highlighting it as a potential therapeutic target for GC treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: RNA modifications and cancer · Epigenetics and DNA Methylation · Cancer-related gene regulation

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Gastrointestinal Surgery Zhongshan Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361004 China

Xiamen Municipal Key Laboratory of Gastrointestinal Oncology Xiamen 361004 China

State Key Laboratory for Cellular Stress Biology School of Life Sciences Xiamen University Xiamen 361104 China

Department of Surgical Oncology and General Surgery Key Laboratory of Precision Diagnosis and Treatment of Gastrointestinal Tumors Ministry of Education The First Affiliated Hospital of China Medical University Shenyang 110001 China

State Key Laboratory of Molecular Vaccinology and Molecular Diagnostics National Institute of Diagnostics and Vaccine Development in Infectious Diseases School of Public Health Xiamen University Xiamen Fujian 361102 China

Department of Pathology Zhongshan Hospital of Xiamen University School of Medicine Xiamen University Xiamen 361004 China

Department of Radiology The First Affiliated Hospital of Xiamen University Xiamen Fujian 361003 China

References (49)

Show source-provided references
1. 10.3322/caac.2166010.3322/caac.21660 ↗
2. 10.1016/S0140-6736(20)31288-510.1016/S0140-6736(20)31288-5 ↗
3. 10.1016/j.cell.2024.03.01110.1016/j.cell.2024.03.011 ↗
4. 10.1038/s41568-023-00557-710.1038/s41568-023-00557-7 ↗
5. 10.1002/ctm2.71910.1002/ctm2.719 ↗
6. 10.15252/embj.201910254110.15252/embj.2019102541 ↗
7. 10.1038/bjc.2014.54310.1038/bjc.2014.543 ↗
8. 10.1016/j.phymed.2021.15349910.1016/j.phymed.2021.153499 ↗
9. 10.1038/s41419-023-05907-910.1038/s41419-023-05907-9 ↗
10. 10.1038/s41586-024-07718-010.1038/s41586-024-07718-0 ↗
11. 10.1038/s41573-020-00108-x10.1038/s41573-020-00108-x ↗
12. 10.1074/mcp.M110.00097610.1074/mcp.M110.000976 ↗
13. 10.1016/j.jbc.2023.10466110.1016/j.jbc.2023.104661 ↗
14. 10.1016/j.abb.2010.05.02310.1016/j.abb.2010.05.023 ↗
15. 10.1371/journal.pone.010539410.1371/journal.pone.0105394 ↗
16. 10.1038/sj.emboj.760017010.1038/sj.emboj.7600170 ↗
17. 10.1038/s41556-021-00793-910.1038/s41556-021-00793-9 ↗
18. 10.1016/j.stem.2016.05.01310.1016/j.stem.2016.05.013 ↗
19. 10.1101/gad.324657.11910.1101/gad.324657.119 ↗
20. 10.1093/bioinformatics/btu11510.1093/bioinformatics/btu115 ↗
21. 10.1038/ncb211210.1038/ncb2112 ↗
22. 10.1038/s41594-023-00988-810.1038/s41594-023-00988-8 ↗
23. 10.1038/cdd.2017.2910.1038/cdd.2017.29 ↗
24. 10.1016/j.atherosclerosis.2023.11719510.1016/j.atherosclerosis.2023.117195 ↗
25. 10.1038/s41580-022-00500-y10.1038/s41580-022-00500-y ↗
26. 10.1074/jbc.M41175720010.1074/jbc.M411757200 ↗
27. 10.1038/s41556-021-00807-610.1038/s41556-021-00807-6 ↗
28. 10.1038/cr.2011.3110.1038/cr.2011.31 ↗
29. 10.1016/j.jbc.2024.10563910.1016/j.jbc.2024.105639 ↗
30. 10.1093/nar/gkw10410.1093/nar/gkw104 ↗
31. 10.1038/s42255-023-00853-410.1038/s42255-023-00853-4 ↗
32. 10.1038/s41568-021-00347-z10.1038/s41568-021-00347-z ↗
33. 10.1016/j.cell.2018.11.03810.1016/j.cell.2018.11.038 ↗
34. Malecki J. · Nucleic Acids Res. · 2017 · 45 · 4370
35. 10.1016/j.molcel.2019.10.01410.1016/j.molcel.2019.10.014 ↗
36. 10.1038/nature0366410.1038/nature03664 ↗
37. 10.1038/s41571-019-0204-610.1038/s41571-019-0204-6 ↗
38. 10.1158/2159-8290.CD-23-030610.1158/2159-8290.CD-23-0306 ↗
39. 10.1038/s41388-023-02689-410.1038/s41388-023-02689-4 ↗
40. 10.1038/nrm347810.1038/nrm3478 ↗
41. 10.1038/s41467-024-51962-x10.1038/s41467-024-51962-x ↗
42. 10.1038/s41419-024-07290-510.1038/s41419-024-07290-5 ↗
43. 10.1038/nature1053910.1038/nature10539 ↗
44. 10.1182/blood-2008-06-16259410.1182/blood-2008-06-162594 ↗
45. 10.1182/blood-2005-08-332510.1182/blood-2005-08-3325 ↗
46. 10.1074/jbc.M10421420010.1074/jbc.M104214200 ↗
47. 10.1038/s41467-024-49875-w10.1038/s41467-024-49875-w ↗
48. 10.1016/j.molcel.2020.05.02510.1016/j.molcel.2020.05.025 ↗
49. Khavrutskii L. · J. Vis. Exp. · 2013 · 78